NASDAQ:SILO | Free Cash Flow | Silo Pharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$822,623.00
2025-12-31-$780,278.00
2025-03-31-$1.64M
2024-12-31-$917,432.00
2024-03-31-$838,179.00
2023-12-31-$910,012.00
2023-03-31-$692,688.00
2022-12-31-$885,989.00
2022-03-31-$789,165.00
2021-12-31-$773,871.00
2021-03-31-$319,318.00
2020-12-31-$536,323.00
2020-03-31-$117,609.00
2019-12-31-$292,804.00
2019-03-31-$149,524.00
2018-12-31-$158,887.00
2018-03-31$191,677.00
2017-12-31-$7,099.00
2013-12-31-$120,625.00
2013-03-31-$10,183.00
2012-12-31-$5,000.00
2012-03-31-$13,039.00
2011-12-31-$6,333.00
2011-03-31-$11,898.00
2010-09-30-$450.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.66M
2024-12-31-$3.83M
2023-12-31-$3.22M
2022-12-31-$3.5M
2021-12-31-$2.28M
2020-12-31-$1.16M
2019-12-31-$794,324.00
2018-12-31$272,637.00
2017-12-31-$284,618.00
2013-12-31-$181,609.00
2012-12-31-$21,473.00
2011-12-31-$46,303.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.